Related Experiment Video
Updated: Aug 18, 2025

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies
Pushpa Singh1, Deepa Bhartiya1
1Stem Cell Biology Department, ICMR-National Institute for Research in Reproductive & Child Health, Parel, Mumbai, India.
In Brief:
Incidence of uteropathies has increased in recent times, possibly due to exposure to endocrine-disrupting chemicals during early development. The present study shows that various uteropathies like endometrial cancer, adenomyosis, and endometriosis are interlinked and occur due to the dysfunction of tissue-resident, very small embryonic-like stem cells (VSELs).
Abstract:
Underlying pathomechanisms leading to the initiation of uteropathies including non-receptive endometrium, hyperplasia, adenomyosis, endometriosis, fibroids, and cancer remain elusive. Two populations of stem cells exist in mouse uterus including pluripotent VSELs and 'progenitors' termed endometrial stem cells (EnSCs) which express ERα, ERβ, PR, and FSHR, participate in the regular remodelling, and maintain life-long homeostasis. The present study aimed to delineate possible stem cell origins for various uteropathies. For this, mouse pups were treated with oestradiol or diethylstilbestrol and were studied for adult onset of various uteropathies. Treatment resulted in disrupted oestrous cycles, reduced uterine weights, and marked hyperplasia in both epithelial and myometrial compartments, and the stromal compartment was also affected. VSELs were increased in numbers as judged by flow cytometry and increased expression of transcripts specific for Oct-4A, Sox-2, and Nanog, but their further differentiation into a receptive endometrium was affected. Reduced 5-methyl cytosine expression suggested global hypomethylation and was associated with several oncogenic events including loss of tumour-suppressor genes (Pten, p53), dysregulated DNA mismatch repair axis, and repair enzymes. Stem cells were epigenetically altered and showed increased expression of DNMTs, loss of imprinting loci (Igf2-H19, Dlk1-Meg3), and Ezh2. Increased co-expression of CD166 and ALDHA1 with OCT-4 in stem cells was associated with increased Esr-2 and reduced Pr in the endometrium, while both were several folds upregulated in the myometrium. Study results suggest that various uteropathies ensue due to the dysfunction of tissue-resident stem cells and provide huge scope for further research.
Insights
Uterine diseases like cancer and endometriosis may stem from dysfunctional very small embryonic-like stem cells (VSELs). Exposure to endocrine disruptors in early development can trigger these stem cell issues, leading to various uteropathies.
Area of Science:
- Reproductive biology
- Stem cell research
- Toxicology
Background:
- Uteropathies, including cancer, adenomyosis, and endometriosis, are increasing.
- The precise mechanisms initiating these conditions remain unclear.
- Tissue-resident stem cells, specifically very small embryonic-like stem cells (VSELs), are implicated.
Purpose of the Study:
- To investigate the role of VSELs in the development of uteropathies.
- To explore the impact of early-life exposure to endocrine-disrupting chemicals on uterine stem cells.
- To identify potential stem cell origins for various uterine diseases.
Main Methods:
- Mouse pups were exposed to oestradiol or diethylstilbestrol.
- Adult offspring were analyzed for uterine health, stem cell populations, and gene expression.
- Flow cytometry and transcript analysis were used to assess VSELs and their differentiation markers.
- Epigenetic modifications, including DNA methylation and imprinting, were examined.
Main Results:
- Exposure led to disrupted cycles, reduced uterine weight, and hyperplasia.
- VSELs increased in number but showed impaired differentiation.
- Global hypomethylation and oncogenic events were observed.
- Epigenetic alterations in stem cells, including altered gene imprinting and Ezh2 expression, were noted.
Conclusions:
- Dysfunction of tissue-resident VSELs is a likely cause of various uteropathies.
- Early-life exposure to endocrine disruptors can epigenetically alter stem cells, promoting disease.
- These findings highlight VSELs as a crucial target for understanding and potentially treating uterine diseases.

